Illuminare Biotechnologies
Brooklyn, US · Founded 2016 · Delaware corporation · 1 known investors
Find your way into Illuminare Biotechnologies
Sign up to see every warm intro you have to Illuminare Biotechnologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Illuminare Biotechnologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BL
Brian LongstreetExecutive
WG
Walter GreenblattNamed on SEC filing
SY
Sue YaoNamed on SEC filing
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$6M disclosed across 2 of 3 rounds · 2017–2026
▶$3.6MraisedJun 2026 · 42 investors · BiotechnologyRule 506(b)
▶$3.6MraisedJun 2026 · 42 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ezra AngristPromoter
- Oliver CurmeDirector
- Walter GreenblattExecutive Officer, Director, Promoter
- Eric EdidinDirector
- Andrew FradkinPromoter
- Brian LongstreetExecutive Officer, Director
- Shay GrinfeldDirector, Promoter
- Robert GraifmanDirector, Promoter
- Offering amount
- $4M
- Amount sold
- $3.6M
- Minimum investment
- $1.4K
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MofferedDec 2018 · BiotechnologyRule 506(b)
▶$2.5MofferedDec 2018 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Walter GreenblattExecutive Officer
- Offering amount
- $2.5M
- Minimum investment
- $5K
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b, 04.3
▶$2.4MraisedAug 2017 · 44 investors · BiotechnologyRule 506(b)
▶$2.4MraisedAug 2017 · 44 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert GraifmanDirector
- Shay GrinfeldExecutive Officer, Director
- Sue YaoDirector
- Offering amount
- $2.5M
- Amount sold
- $2.4M
- Minimum investment
- $5K
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Illuminare Biotechnologies's investors?
- Illuminare Biotechnologies's investors include Greenfield Partners.
- How much funding has Illuminare Biotechnologies raised?
- Illuminare Biotechnologies has disclosed $6M raised across 2 of its 3 known rounds.
- Where is Illuminare Biotechnologies headquartered?
- Illuminare Biotechnologies is headquartered in Brooklyn, US.

